BTIG Initiates Coverage On Omada Health with Buy Rating, Announces Price Target of $30

Benzinga Newsdesk www.benzinga.com Neutral 68.4%

Neg 0% Neu 68.4% Pos 0%

BTIG analyst David Larsen initiates coverage on Omada Health (NASDAQ:OMDA) with a Buy rating and announces Price Target of $30.